Healthcare ❯ Regulatory Affairs

FDA Approvals

Drug Applications Drug Safety Drug Approval Process Drug Indications Drug Development Drug Submissions Veterinary Medicine Drug Efficacy Brinsupri Medical Device Clearance Drug Launches New Drug Formulations Metabolic Disorders

BioMarin to Acquire Amicus for $4.8 Billion in Cash

The takeover expands BioMarin’s rare-disease portfolio with immediate revenue from two marketed therapies.

FDA Adds Brain Tumor Warning to Two Depo‑Provera Injections

Lilly’s Triple-Agonist Retatrutide Shows Major Phase 3 Weight Loss as Grey-Market Use Prompts Warning

Regeneron Tops Q3 Forecasts on Dupixent Strength as Eylea HD Faces FDA Delay

Amgen Reports Repatha Cuts First-Event Risk in Primary-Prevention Trial

Merck Wins FDA Approval for Subcutaneous Keytruda as EU Panel Backs Infant RSV Preventive

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy